Deferred Tax Assets, Valuation Allowance of Pacira BioSciences, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pacira BioSciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $26,130,000, a 5.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $26,130,000 +$1,314,000 +5.3% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $24,816,000 -$704,000 -2.8% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $25,520,000 +$2,589,000 +11% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $22,931,000 +$3,938,000 +21% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q4 2021 $18,993,000 +$16,478,000 +655% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $2,515,000 -$126,576,000 -98% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $6,611,000 +$4,811,000 +267% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q4 2019 $129,091,000 +$10,433,000 +8.8% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $1,800,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $1,800,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q4 2018 $118,658,000 -$1,572,000 -1.3% 31 Dec 2018 10-K 21 Feb 2020 2019 FY
Q4 2017 $120,230,000 -$28,523,000 -19% 31 Dec 2017 10-K 28 Feb 2019 2018 FY
Q4 2016 $148,753,000 +$16,637,000 +13% 31 Dec 2016 10-K 28 Feb 2018 2017 FY
Q4 2015 $132,116,000 +$775,000 +0.59% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q4 2014 $131,341,000 +$9,855,000 +8.1% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q4 2013 $121,486,000 +$17,532,000 +17% 31 Dec 2013 10-K 24 Feb 2015 2014 FY
Q4 2012 $103,954,000 +$20,706,000 +25% 31 Dec 2012 10-K 25 Feb 2014 2013 FY
Q4 2011 $83,248,000 31 Dec 2011 10-K 07 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.